Owens & Minor, Inc. (NYSE:OMI) Shares Purchased by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale boosted its stake in shares of Owens & Minor, Inc. (NYSE:OMI) by 76.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,126 shares of the company’s stock after purchasing an additional 1,356 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Owens & Minor were worth $43,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of Owens & Minor during the fourth quarter worth approximately $9,160,000. Lord Abbett & CO. LLC purchased a new stake in shares of Owens & Minor in the 1st quarter valued at approximately $4,683,000. Vanguard Group Inc. raised its holdings in shares of Owens & Minor by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock valued at $242,459,000 after purchasing an additional 162,182 shares in the last quarter. Kennedy Capital Management LLC lifted its position in shares of Owens & Minor by 42.6% during the 1st quarter. Kennedy Capital Management LLC now owns 525,849 shares of the company’s stock worth $14,571,000 after purchasing an additional 157,038 shares during the last quarter. Finally, Hillsdale Investment Management Inc. acquired a new position in shares of Owens & Minor during the first quarter worth $4,211,000. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Trading Down 1.0 %

Shares of Owens & Minor stock opened at $15.88 on Friday. The company has a debt-to-equity ratio of 2.17, a quick ratio of 0.51 and a current ratio of 1.09. The company has a market capitalization of $1.21 billion, a P/E ratio of -31.14, a PEG ratio of 0.47 and a beta of 0.39. Owens & Minor, Inc. has a 1 year low of $12.36 and a 1 year high of $28.35. The company’s fifty day moving average is $15.51 and its two-hundred day moving average is $18.86.

Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Friday, August 2nd. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.03. The firm had revenue of $2.67 billion for the quarter, compared to analyst estimates of $2.65 billion. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. The business’s revenue was up 4.2% on a year-over-year basis. During the same quarter last year, the company posted $0.18 earnings per share. Analysts forecast that Owens & Minor, Inc. will post 1.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on OMI. StockNews.com cut Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Barclays lowered their price target on Owens & Minor from $23.00 to $18.00 and set an “equal weight” rating for the company in a report on Monday, August 5th. Citigroup upgraded shares of Owens & Minor from a “neutral” rating to a “buy” rating and reduced their price objective for the stock from $24.00 to $19.00 in a research report on Friday, July 19th. Bank of America dropped their target price on shares of Owens & Minor from $18.00 to $16.00 and set an “underperform” rating on the stock in a research report on Tuesday, June 25th. Finally, Robert W. Baird decreased their price objective on shares of Owens & Minor from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Tuesday, July 16th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $20.00.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.